catalyst

Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-002 — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2008-09 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-002 — primary completion
Type
Trial Readout
Date
2008-09
Date type
ACTUAL
Phase
Phase 2
This event happened.
relationships
The graph out of here
trial
Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia
trial